Crestor
Product Images NDC 52959-629

5 FDA label images from H.j. Harkins Company, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Crestor (NDC 52959-629). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by H.j. Harkins Company, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Strucural Formula (Crestor Chem)

Strucural Formula (Crestor Chem)
Chemical structure of the active ingredient in CRESTOR, showing a detailed molecular diagram including fluorophenyl, sulfonylmethyl, and calcium ion components as represented in the formula.*
FDA Label Image

Figure One (Crestor Figone)

Figure One (Crestor Figone)
A box plot chart comparing the percent change from baseline in LDL-C levels for four different statins: CRESTOR, Atorvastatin, Simvastatin, and Pravastatin. The chart shows dose levels in mg for each statin along the x-axis and percentage change on the y-axis, illustrating the variability and median effects of each dosage on LDL-C reduction.*
FDA Label Image

Figure Three (Crestor Figthree)

Figure Three (Crestor Figthree)
A data table comparing the number of events and hazard ratios between Rosuva 20 mg and placebo 20 mg groups across various cardiovascular endpoints. It includes event counts, rates per 1000 patient years, hazard ratios with 95% confidence intervals, and p-values for primary and secondary outcomes such as cardiovascular death, nonfatal stroke, nonfatal MI, unstable angina hospitalization, and arterial revascularization. A forest plot illustrates the hazard ratios and confidence intervals visually.*
FDA Label Image

Figure Two (Crestor Figtwo)

Figure Two (Crestor Figtwo)
A cumulative incidence line graph comparing Rosuva (Rosuvastatin) and Placebo over up to 6 years. The y-axis shows cumulative incidence percentage, and the x-axis shows years. Two lines represent Placebo (dotted) with higher incidence and Rosuva (solid) with lower incidence. The graph includes hazard ratio (HR 0.56) with 95% confidence interval and p-value (<0.001). A table below the graph shows the number at risk for each group at different time points.*
FDA Label Image

Crestor 20mg (90 tablet count bottle label)

Crestor 20mg (90 tablet count bottle label)
Packaging label for CRESTOR 20mg tablet by H.J. Harkins Company, Inc. The label lists NDC 52959-629-30 with lot number CSR01ZA and expiration date 05/13. The manufacturer is AstraZeneca, made in Japan, and the label shows the pill is a pink round tablet, package quantity is 30 tablets. It includes dosage instruction guidance and multiple smaller duplicate labels.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.